Author Question: Drugs that inactivate monoamine oxidase would be expected to A) reduce dopamine levels within the ... (Read 63 times)

sjones

  • Hero Member
  • *****
  • Posts: 520
Drugs that inactivate monoamine oxidase would be expected to
 
  A) reduce dopamine levels within the blood.
  B) elevate acetylcholine levels within the muscles.
  C) reduce serotonin levels in the synaptic cleft.
  D) cause the release of serotonin into the synaptic cleft.
  E) increase dopamine levels within neurons.

Question 2

Deprenyl may delay the progression of symptoms in Parkinson's disease because this drug
 
  A) facilitates monoamine oxidase-A.
  B) reduces dopamine activity in the synapse.
  C) inhibits monoamine oxidase-B.
  D) acts on dopamine autoreceptors.
  E) is a potent D1/D2 agonist.



Jayson

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

Answer: E
Rationale: Drugs that inactivate monoamine oxidase would be expected to increase dopamine levels within neurons.

Answer to Question 2

Answer: C
Rationale: Deprenyl may delay the progression of symptoms in Parkinson's disease because this drug inhibits monoamine oxidase-B.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Increased intake of vitamin D has been shown to reduce fractures up to 25% in older people.

Did you know?

The largest baby ever born weighed more than 23 pounds but died just 11 hours after his birth in 1879. The largest surviving baby was born in October 2009 in Sumatra, Indonesia, and weighed an astounding 19.2 pounds at birth.

Did you know?

According to the American College of Allergy, Asthma & Immunology, more than 50 million Americans have some kind of food allergy. Food allergies affect between 4 and 6% of children, and 4% of adults, according to the CDC. The most common food allergies include shellfish, peanuts, walnuts, fish, eggs, milk, and soy.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library